<?xml version="1.0" encoding="UTF-8"?>
<p>Coronavirus Disease 2019 (COVID-19), caused by the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV), appeared in China for the first time, and subsequently spread worldwide [
 <xref rid="B1-diagnostics-10-00434" ref-type="bibr">1</xref>,
 <xref rid="B2-diagnostics-10-00434" ref-type="bibr">2</xref>]. On 30 January 2020, the World Health Organization (WHO) officially announced the COVID-19 epidemics as a threat to public health internationally, and subsequently, in March 2020, the global situation escalated into the COVID-19 pandemic. Johns Hopkins University reported over 7,600,000 cases of infection and more than 427,000 deaths as of 13 June 2020 [
 <xref rid="B3-diagnostics-10-00434" ref-type="bibr">3</xref>]. As a result of this rapidly progressing COVID-19 pandemic and the limited laboratory-based molecular testing capacities, new point-of-care (POC), scalable rapid diagnostic tests have been invented recently as easy-to-use tools to allow COVID-19 diagnostics outside of laboratory settings. What is more, the urgent need to multiply testing for COVID-19 has been clearly identified as an essential element of the anti-coronavirus strategy all over the world.
</p>
